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The toxic effect of methomyl was studied in rats
after a single or repeated oral administration. Rats
treated with a single dose of methomyl (3, 5, or 7
mg/kg) showed significant increase (P<0.05) in
total lactate dehydrogenase (LDH) activity on day
1. The highest level of LDH activity was observed
on day 3 in rats receiving 7 mg/kg of methomyl.
The total LDH activity returned to normal on day 7
after dosing. Specific increases in LDH-3 and
LDH-4 isoenzyme activities were observed. In
rats treated with a single dose of 6 and 8 mg/kg of
methomyl, spleen weight and splenocyte viability
significantly dropped (P<0.05) on days 1 and 3,
respectively. Splenotoxicity was prevented by
pretreatment with 60 mg/kg of N-acetylcysteine.
The results suggest that the splenotoxic effect of
methomyl is more likely directly related to
oxidative cell injury than to cholinesterase
inhibition. The significance of cytotoxic effects and
the nature of cytotoxicity in relation to reactive
oxidative damage deserve further investigation.
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Methomyl is a monomethylcarbamate insecticide, S-methyl N-(methylcarbamoyloxy)
thioacetimidate, used on a wide range of crops worldwide. Although the recognised
mode of action of methomyl is inhibition of acetylcholinesterase (AChE), similarly to
other carbamate and organophosphorus insecticides, AChE inhibition by methomyl is
reversed more rapidly. Saiyed and co-workers (1) reported that the total lactate dehy-
drogenase (LDH) activity significantly increased in spraymen and was accompanied
by electrocardiogram changes after a 5-day use of methomyl in the field. Gupta and
co-workers (2) indicated that the total LDH activity and the activities of all LDH isoen-
zymes significantly increased at various time intervals in the diaphragm and serum of
rats after a single administration of 5 mg/kg of methomyl. Gupta and co-workers (3)
reported that carbofuran, another monomethylcarbamate, produced characteristic
alterations in creatine kinase (CK), LDH, and their isoenzyme patterns in brain re-
gions, as well as in serum of rats given 1.5 mg/kg of methomyl subcutaneously.
Spleen is a well-known target organ of methomyl toxicity (4).
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This study was undertaken to assess the effects of methomyl on LDH activity
and splenotoxicity in rats.
MATERIALS AND METHODS
Animals
Male Wistar rats (102.4±6.3 g) were obtained from the National Laboratory Animal
Center of the Salaya Campus, Mahidol University. The rats were housed three per
cage in an air-conditioned room (temperature: 23±2 °C) for at least a week before
the experiment. The animals were supplied standard pelleted feed for rats and mice
(C.P. Ltd., Thailand) and tap water ad libitum.
Chemicals
Methomyl of a purity above 98% was donated by DuPont Ltd, Thailand. The chem-
icals for the LDH assay were purchased from Helena Laboratories, USA. The SGPT
Kit was purchased from Clinical Diagnostic Co., Thailand. All other chemicals were
reagent-grade and were purchased from Sigma Chemical Co., USA.
Treatment protocols
Single dose administration of methomyl. After acclimatisation, 96 rats were divided in
four groups; the control and those administered 3, 5, and 7 mg/kg of methomyl.
Methomyl solution diluted in distilled water was given orally by gavage (0.1 ml). On
days 1, 3, 5, and 7 after dosing, six rats from each group were anesthetised for blood
and the organ collection. The organs for histopathological examination included the
liver, heart, spleen, and kidney.
Repeated dose administration of methomyl. Forty-eight rats were divided in two groups:
the control group and the treatment group which was given 5 mg/kg of methomyl for
five consecutive days by gavage. Sampling followed the same protocol as for the
single dose.
Splenotoxicity study. Ninety-six rats were divided in four groups: the control group,
the group treated with 6, and the group treated with 8 mg/kg of methomyl, and a
group pretreated with 60 mg/kg of N-acetylcysteine (NAC) before administration of 8
mg/kg of methomyl. On days 1, 3, and 5 after dosing, eight rats from each group
were anesthetized for blood collection and spleen removal.
Determination of total LDH activity
Total LDH activity was determined according to the method of the Scandinavian
Society for Clinical Chemistry and Clinical Physiology (5). In short, pyruvate was re-
duced to lactate in the presence of LDH at pH 7.4 and 37 °C. The progress of the
accompanying oxidation of NADH to NAD was monitored continuously by measuring
the rate of absorption decrease at 339 nm in the spectrophotometer.
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Determination of LDH isoenzyme activities
LDH isoenzymes were determined according to the method of Helena Laboratories
(6). Each LDH isoenzyme was separated using the electrophoretic technique on cellulose
acetate in tris-barbital-sodium barbital buffer. After the separation, the isoenzymes
could be detected colourimetrically using the Helena LD-VIS isoenzyme reagent, when
a tetrazolium salt was reduced with the formation of a coloured formazan.
Determination of splenotoxicity
Splenotoxicity in rats exposed to methomyl was investigated by comparing the spleen
weight and the splenocyte viability of the treatment groups and the control group (7).
Using to the method of Ellman and co-workers (8), the respective erythrocyte and
spleen AChE activities were determined to assess the effect of the methomyl-induced
splenotoxicity on AChE.
Data analysis
Results are expressed as mean and S.E. for statistical comparison of total LDH activ-
ity, each LDH isoenzyme, and relative organ weight between the control and the
methomyl-treated groups. The statistical analysis consisted of one-way or two-way
ANOVA and post hoc Duncan’s multiple range test. A probability level (P value) of less
than 0.05 was regarded significant.
RESULTS
Clinical signs of methomyl toxicity
The severity of methomyl toxicity in rats, after a single oral administration of meth-
omyl at doses of 3, 5, and 7 mg/kg, was dose-related. Like with other carbamates
and organophosphorus insecticides, the acute toxicity was characterised by nicotinic
and muscarinic signs which persisted from 30 minutes to one hour. The animals
completely recovered within two hours after the methomyl administration. Methomyl
caused no mortality in this study.
In the repeated treatment study, rats receiving methomyl in daily doses of 5 mg/
kg for 5 days showed the same clinical signs of toxicity as observed in a single
treatment study. However, not until the day 3 after dosing did the toxic signs start to
decrease in severity.
Changes in the total LDH and LDH isoenzyme activities
The total LDH activity in the plasma of control rats ranged from 146–184 U/L (N=21)
in the single-dose study to 130–177 U/L (N=24) in the repeated dose study (Tables
1 and 2). On day 1 after a single-dose administration, all treated groups (3, 5, and
7 mg/kg) showed a significant increase (P<0.05) in the total LDH activity when com-
pared to the control.
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Table 1 Total lactate dehydrogenase activity at various time points after oral treatment of rats
with various single doses of methomyl.
Time Control Methomyl Methomyl Methomyl
(after treatment) 3 mg/kg 5 mg/kg 7 mg/kg
Day 1 161.4 ± 17.7 *341.1 ± 8.9* *296.4 ± 10.7* *211.4 ± 37.1*
Day 3 146.4 ± 16.3 108.9 ± 11.8 242.9 ± 57.0 668.6 ± 527.8
Day 5 178.6 ± 27.4 137.1 ± 20.9 156.0 ± 22.2 137.2 ± 18.0
Day 7 184.3 ± 20.7 176.2 ± 6.8 148.6 ± 15.4 165.5 ± 30.2
Values are expressed as mean ± S.E. (N=3–6)
*Significantly different from the control values (P<0.05)
Table 2 Total lactate dehydrogenase activity at various time points after daily treatment
with 5 mg/kg of methomyl for five days.
Time
(after treatment) Control Methomyl
Day 1 130.0 ± 17.3 124.3 ± 25.6
Day 3 154.3 ± 9.6 140.0 ± 6.0
Day 5 177.2 ± 19.8 232.9 ± 99.2
Day 7 177.2 ± 11.4 204.3 ± 54.9
Values are expressed as mean ± S.E. (N=3–6)
Table 3 The number of rats with increased total lactate dehydrogenase (LDH) activity treated
with a single or repeated doses of methomyl
Time aLevels of increased Single dose treatment Repeated 5-day
(after total LDH activity treatment
treatment) 3 mg/kg 5 mg/kg 7 mg/kg 5 mg/kg/day
Day 1 1 1/4 2/4 2/4 1/6
2 3/4 – – –
3 – – – –
4 – – – –
Day 3 1 – – – –
2 – 1/6 – –
3 – 1/6 – –
4 – – 1/6* –
Day 5 1 – 1/6 – –
2 – – – –
3 – – – –
4 – – –     1/6**
Day 7 1 – – 1/6 1/6
2 – – – –
3 – – – 1/6
4 – – – –
a1 = total LDH>1.5–2 times the normal values; 2 = total LDH>2–2.5 times the normal values;
3 = total LDH>2.5–3 times the normal values; 4=total LDH>3 times the normal values.
*The highest total LDH activity in rats treated with a single dose of methomyl of 2779 U/L.
**The highest total LDH activity in rats repeatedly treated with methomyl for five days of 664 U/L.
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One out of six rats treated with the highest dose (7 mg/kg) of methomyl showed
a great increase in the total LDH activity on day 3 (Table 3). In terms of LDH
isoenzymes, rats receiving an oral dose of 7 mg/kg of methomyl showed a signifi-
cant increase in LDH-3 and LDH-4 (P<0.05) on day 3 (Table 4). However, after the
repeated treatment, no significant difference was observed between the control and
the treated animals.
Table 4 Lactate dehydrogenase (LDH) isoenzymes in the plasma of rats treated with an oral dose
of methomyl (3, 5, and 7 mg/kg) at various time points after dosing
Time Group Total LDH activity (%)
(after treatment) LDH-1 LDH-2 LDH-3 LDH-4 LDH-5
Day 1 C 13.8 ± 1.6 5.6 ± 3.2 5.4 ± 2.6 6.4 ± 2.1 68.9 ± 8.6
M3 9.0 ± 2.0 1.9 ± 0.6 2.8 ± 1.6 5.2 ± 1.8 81.1 ± 3.7
M5 6.8 ± 1.8 2.7 ± 1.1 5.1 ± 2.2 6.8 ± 3.1 78.7 ± 7.1
M7 9.2 ± 2.3 1.2 ± 0.0 3.0 ± 1.6 6.3 ± 1.4 80.3 ± 5.1
Day 3 C 17.8 ± 2.8 3.5 ± 1.6 4.7 ± 1.9 5.2 ± 1.8 68.0 ± 5.6
M3 21.6 ± 3.5 2.4 ± 0.8 1.2 ± 0.1 1.8 ± 0.2 73.3 ± 4.2
M5 14.0 ± 2.6 2.3 ± 0.2 1.6 ± 0.7 4.6 ± 1.3 77.6 ± 1.6
M7 8.8 ± 3.6 2.0 ± 0.7 *10.0 ± 2.7* *14.7 ± 4.5* 63.0 ± 5.3
Day 5 C 12.2 ± 1.9 3.6 ± 1.5 5.3 ± 2.0 8.3 ± 2.5 70.9 ± 5.1
M3 17.9 ± 2.7 3.1 ± 1.5 2.5 ± 0.8 4.2 ± 0.9 72.3 ± 3.5
M5 14.8 ± 1.6 4.6 ± 1.7 3.9 ± 1.9 6.0 ± 1.5 70.7 ± 3.4
M7 12.7 ± 0.1 2.4 ± 1.0 2.7 ± 1.0 5.5 ± 1.3 76.7 ± 3.0
Day 7 C 11.5 ± 2.1 3.8 ± 1.1 2.3 ± 1.3 2.8 ± 0.5 79.5 ± 3.1
M3 11.3 ± 1.0 2.4 ± 0.7 2.0 ± 0.5 6.0 ± 1.4 78.4 ± 2.4
M5 12.2 ± 1.9 3.2 ± 1.3 5.2 ± 2.0 6.8 ± 2.5 72.7 ± 4.0
M7 12.2 ± 1.2 7.3 ± 4.1 1.6 ± 0.3 5.3 ± 0.4 73.5 ± 3.9
C=Control; M3=Methomyl 3 mg/kg; M5=Methomyl 5 mg/kg; M7=Methomyl 7 mg/kg.
Values are expressed as mean ± S.E. (N=3–6)
*Significantly different from the control values (P<0.05).
Splenotoxicity and acetylcholinesterase activity
Rats given a single dose of methomyl (6 or 8 mg/kg) showed early signs of dose-
related splenocyte toxicity. The protective effect against methomyl-induced splenotox-
icity was observed in rats pretreated with 60 mg/kg of N-acetylcysteine (NAC). On day
1 after dosing, the absolute and the relative spleen weight and splenocyte viability in
rats receiving 6 of 8 mg/kg of methomyl were significantly lower (P<0.05) than in the
control animals. No significant toxic effects were observed in NAC-pretreated rats
(Table 5).
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Table 5 Acetylcholinesterase (AChE) activity, absolute and relative spleen weight, and splenocyte
viability in rats treated with 6 and 8 mg/kg of methomyl, rats pretreated with 60 mg/kg of N-acetylcysteine
followed by 8 mg/kg of methomyl, and the control groups at various time points  after dosing
Day(s) after Group AChE activity Spleen weight Splenocyte
 treatment (U/g Hgb) (g) (% of body weight) viability(%)
1 C 8.34 ± 1.77 0.995 ± 0.112 0.48 ± 0.05 84.8 ± 3.7
M6 7.15 ± 1.18 *0.904 ± 0.035* 0.45 ± 0.03 **63.5 ± 9.5**
M8 7.58 ± 1.73 *0.877 ± 0.051* 0.44 ± 0.04 ** 57.2 ± 10.8**
NAC+M8 7.69 ± 1.62 1.004 ± 0.104 0.49 ± 0.04 81.5 ± 5.9
5 C 9.41 ± 3.45 1.043 ± 0.160 0.49 ± 0.06 80.9 ± 1.8
M6 8.21 ± 1.55 0.917 ± 0.067 *0.43 ± 0.03* 73.5 ± 7.0
M8 8.57 ± 2.99 0.927 ± 0.047 0.44 ± 0.02 69.3 ± 4.9
NAC+M8 9.64 ± 2.18 1.012 ± 0.062 0.48 ± 0.02 81.4 ± 2.3
7 C 8.01 ± 1.86 1.082 ± 0.176 0.45 ± 0.06 82.1 ± 4.5
M6 7.60 ± 1.62 0.977 ± 0.135 0.42 ± 0.04 80.7 ± 1.7
M8 7.47 ± 1.31 0.965 ± 0.118 0.43 ± 0.06 76.5 ± 7.9
NAC+M8 8.20 ± 2.79 1.012 ± 0.041 0.44 ± 0.03 80.1 ± 3.2
C = control; M6 = methomyl 6 mg/kg; M8 = methomyl 8 mg/kg; NAC = N-acetylcysteine 60 mg/kg
Values are expressed as mean ± S.D. (N=4–8)
Significantly different from the control values: *P<0.05; **P<0.01 (Student’s t-test).
DISCUSSION
Oral administration of even the lowest dose of methomyl (3 mg/kg) caused marked
cholinergic signs within five minutes after dosing. However, these toxic effects were
soon annulled by rapid metabolism and elimination of methomyl and spontaneous
reactivation of acetylcholinesterase. After a repeated administration of methomyl, no
cumulative toxicity or signs of toxicity were observed and the rats recovered before the
following administration.
Regarding the changes in the total LDH activity and LDH isoenzymes, the in-
crease in the total plasma LDH activity in rats which received a single dose of meth-
omyl was observed on days 1 and 3 after administration. The enzyme activity returned
to the normal level on days 5 and 7. The findings indicate that the effects of meth-
omyl are reversible. The enzymatic recovery may be explained by the short half-life of
LDH, the cessation of effects, and/or the rapid excretion of methomyl.
On day 3, acetylcholinesterase activity was not significantly reduced due to a
rapid spontaneous reactivation of the carbamylated enzyme. However, the significant
increase in LDH-3 and LDH-4 was noted on day 3 at the dose level of 7 mg/kg of
body weight.
There is a limited number of studies that deal with the distribution of LDH
isoenzymes in various organs of rats. Further studies should focus on the precise
sources of LDH-4 and on the effects of methomyl on other organs. In rats, LDH-4
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was predominant in the spleen (7) and pulmonary vascular endothelium (9). The
spleen and/or vascular endothelial cells are possible targets of methomyl toxicity.
There were slight changes in the liver and spleen of rats treated with methomyl.
These alterations may involve injury which also reflects in significant changes in LDH-
3, LDH-4, and in the decrease in relative weight of rat liver. However, there were no
differences from the controls. Furthermore, there was no change in the transaminase
(SGPT) activity in any of the groups, which suggests that methomyl may not be
involved in the hepatic cell injury (unpublished data).
Rats orally treated with a single dose of 6 and 8 mg/kg of methomyl manifested
a decrease in both spleen cell viability and spleen weight. There is increasing evidence
that the oxidative stress and free radical damage in the cellular components is a
consequence of toxic exposure. Reactive oxidative damage appears to participate in
either genotoxic or non-genotoxic mechanisms such as down regulation of cell to cell
communication, increased proliferation, or decreased apoptosis. Busey (10) observed
glutathione reduction in human lymphocyte exposed to methomyl in vitro, as well as
an increase in micronuclei and chromosomal aberrations. Methomyl induced chro-
mosomal aberrations in the mouse spleen cell within 24 hours after intraperitoneal
injection of 1 mg/kg of methomyl (11).
Our later and yet unpublished experiments suggest that methomyl appears to
produce such chromosomal effects through cytoskeleton impairment.
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Sa‘etak
AKTIVNOSTI IZOENZIMA LAKTAT DEHIDROGENAZE I U^INCI NA
SLEZENU [TAKORA TRETIRANIH METOMILOM
Istra‘ivani su u~inci karbamatnog insekticida metomila u {takora. Nakon jednokratne peroralne doze od 3, 5 ili
7 mg/kg na|eno je zna~ajno pove}anje sveukupne aktivnosti laktat dehidrogenaze (LDH) nakon prvog dana
tretmana. Najve}a je aktivnost utvr|ena tre}eg dana nakon tretmana metomilom u dozi od 7 mg/kg. Enzimska
aktivnost postepeno se smanjivala i sedmoga se dana normalizirala. Posebno je zapa‘eno pove}anje aktivnosti
izoenzima LDH-3 i LDH-4.
U posebnim je pokusima utvr|eno zna~ajno smanjenje te‘ine slezene i vitalnosti splenocita u {takora tretiranih sa
6 i 8 mg/kg metomila i to nakon prvog i nakon tre}eg dana tretmana. Toksi~ni u~inci na slezenu mogli su se
sprije~iti pretretiranjem sa 60 mg/kg N-acetilcisteina. Prema rezultatima ovih pokusa ~ini se da bi toksi~ni u~inak
metomila na slezenu mogao biti izravan u~inak metomila na stanice slezene a ne putem kolinergi~nog mehanizma.
Va‘nost ovakvog citotoksi~nog u~inka i mehanizme citotoksi~nosti i njihove povezanosti s reaktivnim oksidativnim
procesima pri stani~nom o{te}enju valja jo{ istra‘ivati.
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insekticidi, karbamati, kolinesteraza, slezena
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